LEF1 haploinsufficiency causes ectodermal dysplasia.


Journal

Clinical genetics
ISSN: 1399-0004
Titre abrégé: Clin Genet
Pays: Denmark
ID NLM: 0253664

Informations de publication

Date de publication:
04 2020
Historique:
received: 25 10 2019
revised: 28 01 2020
accepted: 30 01 2020
pubmed: 6 2 2020
medline: 4 6 2021
entrez: 6 2 2020
Statut: ppublish

Résumé

Ectodermal dysplasias are a family of genodermatoses commonly associated with variants in the ectodysplasin/NF-κB or the Wnt/β-catenin pathways. Both pathways are involved in signal transduction from ectoderm to mesenchyme during the development of ectoderm-derived structures. Wnt/β-catenin pathway requires the lymphoid enhancer-binding factor 1 (LEF1), a nuclear mediator, to activate target gene expression. In mice, targeted inactivation of the LEF1 gene results in a complete block of development of multiple ectodermal appendages. We report two unrelated patients with 4q25 de novo deletion encompassing LEF1, associated with severe oligodontia of primary and permanent dentition, hypotrichosis and hypohidrosis compatible with hypohidrotic ectodermal dysplasia. Taurodontism and a particular alveolar bone defect were also observed in both patients. So far, no pathogenic variants or variations involving the LEF1 gene have been reported in human. We provide further evidence for LEF1 haploinsufficiency role in ectodermal dysplasia and delineate its clinical phenotype.

Identifiants

pubmed: 32022899
doi: 10.1111/cge.13714
doi:

Substances chimiques

CTNNB1 protein, human 0
LEF1 protein, human 0
Lef1 protein, mouse 0
Lymphoid Enhancer-Binding Factor 1 0
NF-kappa B 0
beta Catenin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

595-600

Informations de copyright

© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Freire-Maia N. Heterogeneity among ectodermal dysplasias. J Med Genet. 1977;14(3):234. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1013568/
García-Martín P, Hernández-Martín A, Torrelo A. Ectodermal dysplasias: a clinical and molecular review. Actas Dermosifiliogr. 2013;104:451-470.
Reyes-Reali J, Mendoza-Ramos MI, Garrido-Guerrero E, Méndez-Catalá CF, Méndez-Cruz AR, Pozo-Molina G. Hypohidrotic ectodermal dysplasia: clinical and molecular review. Int J Dermatol. 2018;57:965-972.
Cluzeau C, Hadj-Rabia S, Jambou M, et al. Only four genes (EDA1, EDAR, EDARADD, and WNT10A) account for 90% of hypohidrotic/anhidrotic ectodermal dysplasia cases. Hum Mutat. 2011;32:70-77.
Zhang Y, Tomann P, Andl T, et al. Reciprocal requirements for EDA/EDAR/NF-κb and Wnt/β-catenin signaling pathways in hair follicle induction. Dev Cell. 2009;17:49-61.
Schmidt-Ullrich R, Paus R. Molecular principles of hair follicle induction and morphogenesis. Bioessays. 2005;27:247-261.
Sadier A, Viriot L, Pantalacci S, Laudet V. The ectodysplasin pathway: from diseases to adaptations. Trends Genet. 2014;30:24-31.
Durmowicz MC, Cui CY, Schlessinger D. The EDA gene is a target of, but does not regulate Wnt signaling. Gene. 2002;285:203-211.
Clevers H. Wnt/β-catenin signaling in development and disease. Cell. 2006;127:469-480.
Kratochwil K, Galceran J, Tontsch S, Roth W, Grosschedl R. FGF4, a direct target of LEF1 and Wnt signaling, can rescue the arrest of tooth organogenesis in Lef1−/− mice. Gene Dev. 2002;16:3173-3185.
Van Genderen C et al. Development of several organs that require inductive epithelial-mesenchymal interactions is impaired in LEF-1-deficient mice. Genes Dev. 1994;8:2691-2703.
Zhou P, Byrne C, Jacobs J, Fuchs E. Lymphoid enhancer factor 1 directs hair follicle patterning and epithelial cell fate. Genes Dev. 1995;9:700-713.
Laurikkala J, Pispa J, Jung HS, et al. Regulation of hair follicle development by the TNF signal ectodysplasin and its receptor Edar. Development. 2002;129:2541-2553.
Brugmann SA, Goodnough LH, Gregorieff A, et al. Wnt signaling mediates regional specification in the vertebrate face. Development. 2007;134:3283-3295.
Takeda H, Lyle S, Lazar AJF, Zouboulis CC, Smyth I, Watt FM. Human sebaceous tumors harbor inactivating mutations in LEF1. Nat Med. 2006;12:395-397.
Huang N, Lee I, Marcotte EM, Hurles ME. Characterising and predicting haploinsufficiency in the human genome. PLoS Genet. 2010;6:1-11.
Lek M, Karczewski KJ, Minikel EV, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285-291.
Plaisancié J, Bailleul-Forestier I, Gaston V, et al. Mutations in WNT10A are frequently involved in oligodontia associated with minor signs of ectodermal dysplasia. Am J Med Genet Part A. 2013;161:671-678.
Clauss F, Waltmann E, Barriere P, Hadj-Rabia S, Manière MC, Schmittbuhl M. Dento-maxillo-facial phenotype and implants-based oral rehabilitation in Ectodermal Dysplasia with WNT10A gene mutation: Report of a case and literature review. J Cranio-Maxillofacial Surg. 2014;42:e346-e351.
He H, Han D, Feng H, et al. Involvement of and interaction between WNT10A and EDA mutations in tooth agenesis cases in the Chinese population. PLoS One. 2013;8:e80393.
Gomes RR, Habckost CD, Junqueira LG, et al. Taurodontism in Brazilian patients with tooth agenesis and first and second-degree relatives: a case-control study. Arch Oral Biol. 2012;57:1062-1069.
Bailleul-Forestier I, Molla M, Verloes A, Berdal A. The genetic basis of inherited anomalies of the teeth. Part 1: Clinical and molecular aspects of non-syndromic dental disorders. Eur J Med Genet. 2008;51:273-291.
Bailleul-Forestier I, Berdal A, Vinckier F, de Ravel T, Fryns JP, Verloes A. The genetic basis of inherited anomalies of the teeth. Part 2: syndromes with significant dental involvement. Eur J Med Genet. 2008;51:383-408.

Auteurs

Jonathan Lévy (J)

Genetics Department, AP-HP, Robert-Debré University Hospital, Paris, France.

Yline Capri (Y)

Genetics Department, AP-HP, Robert-Debré University Hospital, Paris, France.

Myriam Rachid (M)

Genetics Department, AP-HP, Robert-Debré University Hospital, Paris, France.

Céline Dupont (C)

Genetics Department, AP-HP, Robert-Debré University Hospital, Paris, France.

Joris R Vermeesch (JR)

Department of Human Genetics, KU Leuven, Leuven, Belgium.
Center of Human Genetics, University Hospitals Leuven, Leuven, Belgium.

Koen Devriendt (K)

Department of Human Genetics, KU Leuven, Leuven, Belgium.
Center of Human Genetics, University Hospitals Leuven, Leuven, Belgium.

Alain Verloes (A)

Genetics Department, AP-HP, Robert-Debré University Hospital, Paris, France.

Anne-Claude Tabet (AC)

Genetics Department, AP-HP, Robert-Debré University Hospital, Paris, France.
Neuroscience Department, Génétique Humaine et Fonction Cognitive Unit, Pasteur Institute, Paris, France.

Isabelle Bailleul-Forestier (I)

Department of Paediatric Dentistry, Rare Oral and Dental Competence Center, CHU Toulouse, Paul Sabatier University, Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH